Poland - Pharmaceutical products

Description

The subject of the contract is the supply of medicinal products for the CZMP Institute, with the assortment and quantities specified in the Price Form attached as Annex 2 to the ToR.
Package No. 11. Spray preparation containing siloxanes, without alcohol and organic solvents for painless removal of, among others, self-adhesive dressings, fixing tapes, for newborns (including infants), children and pregnant women. Capacity 50 ml. 600 fl. Package no. 21. Thrombinum + Fibrinogenum 2 IU +5.5 mg, medicinal sponge, sterile 2.5cmx3cmx0.5cm, pcs. 240 pcs. Package no. 31. Aqua sterilisata; irrigation fluid bottle with profiled outlet and screw cap 250 ml 1 000 fl. Package no. 41. Aqua sterilisata; irrigation fluid bottle with profiled outlet and screw cap 500 ml 5 000 fl. Package No. 51. Omeprazoleum, hard germ caps [0.01 g] 280 tablets /drag /caps.2. Misoprostolum; tablets. Aluminium phosphas, oral. [0.045 g/g] fl. 250g 100 fl.4. Omeprazoleum; hard germ caps [0.02 g] 19,600 tablets/yadjund/caps.5. Hyoscini butylbromidum; solution for shock. Oxybutyninum, Table 1. Mebeverinum, caps. Simethiconum, caps. Simeticon drops oral 40 mg/1 ml suspension. Package 30 ml 300 ml10. Dimeticonum; oral drops [0.98 g/g] 3 250 ml11. Cisapridum, table. Cisapridum, Table 10. Cisapridum, Table 5 mg 120 Tables/thrash/caps.13 Trimebutini maleas; Table 5 mg Metoclopramidum; solution for shock. Metoclopramidum; table. Drotaverinum; Table 4 500 tabl./drag./cap.16. Drotaverinum; Cap.17. Drotaverinum; Hypodermic shock. 750 amp.18. Drotaverinum; table. 60,000 tabl./yrag./cap.19. Amylasum+Lipasum+Proteasum, cap. 50 tabl./yrash./cap.20. Papaverinum; shock solution. Silymarinum, hard caps [0.07 g] 1,200 tabl./drag./caps.22. Alverini citras; hard caps [0.06 g] 300 tabl./drag./caps.23. Sylimarinum; tabl./drag. Glycerolum; - [1 g] suppositories 4,000 units 25. Glycerolum; - [2 g] suppositories 6,000 units 26. Macrogoli 3350 in 5 g sachets. Oral osmotic medical device, gluten-free, for children over 6 months of age. 2,400 sasz.27. Macrogolum; powder to sp.solution [-] 1,200 sasz.28. Lactulosum; syrup [9.75 g/15ml] fl. 200 ml 1,100 fl.29. Mesalazinum 0.5 g intestinal tablets indicated for ulcerative colitis 400 tabl./drag./caps.30. Electrolyte-containing powder, 100 ml contains: 1.73 g glucose, 140 mg sodium, 200 mg chloride, 80 mg potassium, 190 mg citrate; osmolarity 234 mOsm/l. Sachets a 5 g. 20 sachets.31. Recadotrilum; granules for p.o.c. Loperamidum; table. Nifuroxazidum; table topping. Nystatinum, gastrointestinal tract. Mesalazinum; lead-in release table. Mesalazinum, rectal (4 g/60 ml) 4 fl. Package no. 61. Metforminum; tabl.powl. 3,000 tabl./drag./caps.2. Metforminum; powl. 1,200 tabl./drag/caps.3. Metphorminum; tabl.powl. Metphorminum, Pre-release table, 600 tabl./drag./caps.4. Package No. 71. Alfacalcidolum; soft caps [1 mcg] 500 tablets/yield/cap 2. Vit. B1 inj. 0.1 g 1 000 amp. Package 81. Calcii carbonas; hard caps [0,4 g Ca2+] 3 000 tabl. /drag./caps.2. Calcii chloridium, solution for injection. Calcii glubionas + Calcii carbonas, mousse. Calcii glubionas + Calcii lactobionas, syrup [0,114 g Ca2+/5ml] 300 fl.5. Calcium chloride, syrup [0,782 g K+/10ml] 50 fl.6. Calcium chloride, solution for infusion. [0,15 g/ml] vial. 20ml 20 000 vials.7. Kalia carbonas + Kalia chloridim; gran.must. [0.782 g K+/3g] 300 sash. Package No. 91. Magnesia sulfas, solution to shock. 70,000 amp Package 101. Phytomenadionum; solution for shaking. [0.01 g/ml] 3,000 amps. Package 111. Levosimendanum; end of infusion. [2.5 mg/ml] 80 amps. Package No. 121. Sildenafilum; pr.do p.zaw.ust. [0.01 g/ml] 22 fl. Package No. 131. Sildenafilum film-coated tablets 20 mg packet. 90 tablets. Registered in the drug program for treating pulmonary hypertension 1 260 tablets/yaddress/caps. Package No. 141. Dopamine; solution for infusion [0.01 g/ml] 4 000 amp.2. Dopamine; solution for infusion [0.04 g/ml] 2 000 amp. Norepinephrinum; solution for infusion [1 mg/ml] amp 1 ml 5 000 amp 2. Norepinephrinum, intravenous injections [1 mg/ml], amp. 4 ml 2 000 amp. Pack 161. Dobutamine, intravenous injections 250 mg, vial.s.subst. 1 200 amp. Package No. 171: Atracurii besilas; solution for injection and infusion [0.01 g/ml] amp. 5ml 6,000 amp.2. Mivacurii chloridium; injection solution [0.01 g/ml] amp. [2 mg/ml] amp. 5 ml 750 amp. Packet No. 181. Progesteronum, solution for injection 0.025 g vial and 1.119 ml x 7 vial. 720 vial. Packet No. 191. Betamethasonum, injection 4 mg/1 ml, amp. 1 ml 3 200 amp. Package 201. Amikacinum; injection and infusion solution [0.125 g/ml] 4 000 amp.2. Amikacinum; injection and infusion solution [0.25 g/ml] 600 amp.3.Ceftriaxonum, solution for infusion [1 g] 9 000 vials [2 g] 500 vials [2 g] Ceftazidimum; solution for inj./dom. Ceftazidimum; inj./home. Ciprofloxacinum; coating table; Ceftazidimum; pr.do inj./dom. Ciprofloxacinum; table of coating. Colistinum; p.p.solution for infusion [1,000,000 IU] 4,400 vials of 10. Doxycyclinum; solution for infusion [0.02 g/ml] 100 amp.11. Furaginum, table. Collagenum + Gentamicinum, cm), gelatinum sponge/hemorrhage. Gentamicinum; solution for house shock. [0.04 g/ml] amp. 2 ml 6,000 amp.14. Ertapenemum; sp.z.p. concentrate; dissolution for infusion [1 g] 30 vials.15. Clindamycinum, hard [0.3 g] 400 tabl./drag./cap.16. Clarithromycinum, powl. Metronidazolum; solution for injection and infusion [5 mg/ml] amp. 20 ml 2,000 amp.18. Metronidazolum; solution for infusion and infusion [5 mg/ml] x 100 ml 20,000 fl.19. Metronidazolum, dopochococcal table [0.25 g] 560 tablets. Nifuroxazidim, hard caps [0.2 g] 84 tablets/yaddrage/caps.21. Nifuroxazidim, oral. [0.22 g/5ml] 60 fl.22. Amoxicillinum, table top. 80 tablets/caps.23. Amoxicillinum, powl. 160 tabl./dragon/cap.24. Amoxicillinum, table top. 320 tabl./drag./cap.25. Benzylpenicillinum; pr.do inj.doż./dom. [1,000,000 IU] 200 vials.26. Benzylpenicillinum; pr.do inj./dom. [3 million IU] 30 vial.27. Benzylpenicillinum procainum; pr.do inj.dom. [1 200 000 IU] 30 vial.28. Benzylpenicillinum procainum; pr.do inj.dom. [2,400,000 IU] 30 vials.29. Piperacilinum + Sulbactamum; sp./solution [4g+0.5g] 650 vial.30. Spiramycinum; coating table. [1.5 million IUU] 3,520 tablets /dramycinum /caps.31. Spiramycinum; tabl.powl. Sulperazonum; sp.solution [2g] 20 vials.33. Cloxacilinum; sp.solution for infusion [1 g] 600 vials.34. Claritromycinum; sp.solution for infusion [1 g] 600 vials.34. Claritromycinum; sp.solution for infusion. Cefuroximum; irritant table. Amoxicillinum granules for the preparation of an oral suspension of 0.25 g/5ml 3 000 ml37. Cefuroximum, granules for oral suspension. [0.125 g/5ml] 18 000 ml Package 211. Cefazolinum; pr.do inj./dom. Cefepim powder for solution for injection and infusion 1 g 20 vials, 231 Meropenemum; p.p. solution for infusion [0,5 g] 7 000 vials, 241 Amphotericinum B; p.p. solution for liposomal dispersion for infusion [0,05 g] 50 vials 2Flucytosinum, solution for infusion [0,01 g/ml] fl.a 250ml 30 fl.3. Fluconazolum; cap. Fluconazolum, cap. Fluconazolum; hard caps [0.1 g] 1,400 tablets of fluconazolum; syrup [5 mg/ml] x 150 ml 12,000 ml7. Amphotericinum B, powder for the preparation of inj. 50 mg 50 vial. Package No. 251. Aciclovirum; coating table. Aciclovirum; powl. [0.2 g] 3 000 tabl./drag./caps.2. 600 tabl./draż./cap.3. Aciclovirum, tabl.powl. Oseltamivirum, hard caps [0.03 g] 300 tabl./drag./caps.5. Oseltamivirum, hard caps [0.045 g] 100 tabl./drag./caps.6. Oseltamivirum, hard caps [0.075 g] 50 tabl./drag./caps.7. Valgancyclovirum, doust. 0.05 g/ml x 100 ml 400 ml8. Amantadini hydrochloride, cap. 200 tabl./drag./caps.9. Voriconazolum, powl. Voriconazolum; sp. and dissolution for infusion. Mitoxantronum, concentrate for solution for infusion, 2 mg/ml vial 10 ml, chemical-physical stability of the prepared solution 28 days at 2-8°C 200 vials Pack 271. Mycophenolas mofetil, sp. z o.o. powder Oral use. [1 g/5ml] x 110 g (175 ml) 220 g2. Ciclosporinum, cap.elast. Ciclosporinum, cap.elast. [0,025 g] 250 tabl./drag./caps.3. Ciclosporinum, caps.elast.(gelatine) [0.05 g] 250 tabl./yred/caps.5. Mycophenolas mofetil; table topping. 250 tabl./yred/caps. Package No. 281. Ibuprofenum; oral. [0.02 g/ml] 110,000 ml2. Ketoprofenum; hard caps [0.05 g] 12,000 tabl./drag./caps.3. Paracetamolum; tabl. 45,000 tablets/yield/caps.4. Paracetamolum, tenon. 200,000 units. Paracetamolum, tenon. 100 pcs. 6. Paracetamolum, tenon. 40 pcs. 7. Paracetamolum, tenon. Acidum acetylsalicylicum, table. 800 tablets/yard/caps. Package no. 291. Tramadolum, shock solution. Tramadolum, Pre-emergence table, [0.1 g/2ml] 1 250 amp.2. Tramadolum; cap. Package 301. Ketoprofenum; shock solution. [0.05 g/ml] amp. 2 ml 35 000 amps. Package 311. Fentanylum; syst.transderm., plast. [0.025 mg/h (2.75 mg)] 50 sasz. Package 321. Dexmedetomidinum; end of the infusion. 10ml 640 vials. Package 331. Midazolamum, intravenous injections 1 mg/1 ml, amp. 5 ml 20,000 amp.2. Midazolamum, intravenous injections 1 mg/1 ml, amp. 5 ml. 330 amp.3. Midazolamum, intravenous injections 5 mg/1 ml, amp. 1 ml 11 600 amp.4. Midazolamum; solution for injection. [5 mg/ml] amp. 10 ml 1 000 amp.5. Midazolamum, intravenous injections 5 mg/1 ml, amp. 3 ml 2 050 amp. Package No. 341. Piracetamum, table top. Piracetamum, solution for infusion [12 g/60ml] 400 fl.3. Piracetamum, solution for shock. [0.2 g/ml] amp. 2 ml 360 amp.4. Pyridostigminum; tablets of irritants. 900 tablets of irritant/capsule. Betahistini hydrochloridim; tablets. Acetylcysteinum, solution for infusion [0.1 g/ml] amp. 3ml 1 250 amp. Package no. 361. Aqua pro iniectione; rozp.do sp.lek.parent. Amp. 10 ml 220 000 amp.2. Natrii Chloride; inj. [0.1 g/ml] amp.a 10ml 24 000 amp. Trace element solution for parenteral nutrition of premature infants, intravenous injections, vial. 10 ml 2 000 vials. Package 381, Water soluble vitamins solution for parenteral nutrition for children and adults, intravenous injections, vial.s.subst. Vitamin K solution for parenteral nutrition of premature infants, intravenous injections, amp. concentrate or vial 10 ml 7 000 vials. Package 401. Glucosum; solution for infusion [0.05 g/ml] x 1 wor.a 250ml 1 000 bags2. Glucosum; solution for infusion [0,05 g/ml] x 1 vial 500ml 1 500ml bag3. Glucosum; solution for infusion [0.05 g/ml] x 1 bag a 50ml 500ml sack4. Glucosum; solution for infusion [0.1 g/ml] x 500 ml (bag) 2 000 bags 411. Mannitolum; solution for injection and infusion [0.2 g/ml] x 100 ml (glass) 2 000 fl.2. Mannitolum, solution for injection and infusion [0.2 g/ml] x 250 ml (glass) 100 fl.3.Natrii Chloridim; solution for infusion [9 mg/ml] x 1 l (flat oval bottom with caps.) 6 500 fl.4. Natrii Chloridim; solution for infusion [9 mg/ml] x 100 ml polypropylene container clear 110 000 fl.5.Natrii Chloridiam; solution for infusion [9 mg/ml] x 250 ml polypropylene clear 100 000 fl.6. Natrii Chloridiam; solution for infusion [9 mg/ml] x 500 ml (capsule capacity) 30 000 fl.7Natrii Chloridim + Calcium Chloridim + Calcii Chloridim, solution for infusion [(8,6mg+0,3mg+0,33mg)/ml] x 500 ml (two-port capacity KabiPac) 28 000 fl.8Multi-electrolyte liquid, isotonic, lactate free, intravenous injections, standing bottle with stopper with two ports 500 ml 72 000 fl.9. Multi-electrolyte isotonic liquid with composition: Na - 145 mmol/l, K-4 mmol/l, Ca- 2.5 mmol/l, Mg-1 mmol/l, chlorides 127 mmol/l, acetates -24 mmol/l, malates - 5 mmol/l, osmolarity 309mOsm/l. Flask 250 ml. 600 fl. Glucosum, solution for infusion [0.05 g/ml], 250 ml capacity 2 500 fl.2. Glucosum, solution for infusion [0.05 g/ml], 500 ml capacity 2 000 fl.3. Natrii chloridium, %, solution for irrigation, - [9 mg/ml] bottle with profiled outlet and screw cap 500 ml 7 000 fl.4Solution for rinsing in a 1000 mll bottle with screw cap 600 fl.5. [9 mg/ml] but.a 100ml 20 000 fl.7. Natriya Chlorida; solution for shaking. [9 mg/ml] but.a 500ml 20 000 fl.8. Nitrium chloride; solution for injection [9 mg/ml] but.a 500ml 20 000 fl.8. [9 mg/ml] but 250ml 20 000 fl. Package No. 431. Natrii bicarbonas, solution for injection. Apixabanum Table 2.5 mg 720 table/yrash/caps.2Apixabanum table 5 mg 672 table/yaddress/cap. Package 451. Insulini injectio neutralis, insulin injection [100 IU/ml] x 1 vial and 10ml 500 vials. Package 461. Enoxaparinum natricum; dissolution for subcutaneous injection. [0.02 g/0.2ml] Ordering party requires a product that does not require additional safety monitoring of 100 s-amp2 therapy. Enoxaparinum natricum; solution for subcutaneous shock. [0.04 g/0.4ml] The awarding authority requires a product that does not require additional safety monitoring of the therapy 800 s-amp Package 471. Cyclophosphamidum pr for p. 1 g 1 300 vial infusion solution.

Opportunity closing date

17 June 2020

Value of contract

to be confirmed